<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.forbes.com/innovation/feed2</title><link>https://www.forbes.com/innovation/feed2</link><description>Individual feed output.</description><lastBuildDate>Thu, 31 Jul 2025 07:09:08 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Do Not Reset Your Password — FBI Issues Critical New Warning</title><link>https://www.forbes.com/sites/daveywinder/2025/07/31/do-not-reset-your-password---fbi-issues-critical-new-warning/</link><image_url>https://imageio.forbes.com/specials-images/imageserve/688b446b5538e0bfadc1e111/0x0.jpg?width=960</image_url><description>The FBI has updated its advice as Scattered Spider cyberattacks continue — do not reset your password.</description><pubDate>Thu, 31 Jul 2025 11:58:17 GMT</pubDate></item><item><title>How AI And Mini-Organs Could Replace Testing Drugs On Animals</title><link>https://www.forbes.com/sites/alexknapp/2025/07/31/how-ai-and-mini-organs-could-replace-testing-drugs-on-animals/</link><image_url>https://imageio.forbes.com/specials-images/imageserve/688a66f8d5892b4272db9cc5/0x0.jpg?width=960</image_url><description>Congress and the FDA are pushing pharmaceutical companies to replace animals with technology for drug research. That’s a long way off, but startups an...</description><pubDate>Thu, 31 Jul 2025 11:30:00 GMT</pubDate></item><item><title>How A 60-Year-Old Drug Developer Built A $4.4 Billion Biotech Treating ‘Butterfly Skin Disease’</title><link>https://www.forbes.com/sites/amyfeldman/2025/07/31/the-butterfly-skin-disease-centimillionaire/</link><image_url>https://imageio.forbes.com/specials-images/imageserve/6887c82ada8546680bdd2e60/0x0.jpg?width=960</image_url><description>Longtime drug developer Suma Krishnan was 51 when she cofounded Krystal Biotech. Now the company has one gene therapy on the market and more in the wo...</description><pubDate>Thu, 31 Jul 2025 11:30:00 GMT</pubDate></item><item><title>CVS Profits Eclipse $1 Billion As Aetna’s Costs Begin To Stabilize</title><link>https://www.forbes.com/sites/brucejapsen/2025/07/31/cvs-profits-eclipse-1-billion-as-aetnas-costs-begin-to-stabilize/</link><image_url>https://imageio.forbes.com/specials-images/imageserve/688ac00ea177e200eb27f541/0x0.jpg?width=960</image_url><description>CVS Health reported $1 billion in second quarter profits as the company gets a handle on costs that have dogged its Aetna health insurance unit and ri...</description><pubDate>Thu, 31 Jul 2025 11:30:00 GMT</pubDate></item><item><title>Why Optical Infrastructure Is Becoming Core To The Future Of AI</title><link>https://www.forbes.com/sites/kolawolesamueladebayo/2025/07/31/why-optical-infrastructure-is-becoming-core-to-the-future-of-ai/</link><image_url>https://imageio.forbes.com/specials-images/imageserve/688b4215ed8f471431c79475/0x0.jpg?width=960</image_url><description>AI models are getting smarter, but most of their infrastructure is still stuck in the past. Silicon photonics could change that.</description><pubDate>Thu, 31 Jul 2025 11:23:34 GMT</pubDate></item></channel></rss>